Undoctored vault view

PHARMAC is pleased to provide another treatment option for patients with severe osteoporosis following the funding of denosumab, brand name Prolia, from 1 July 2018.

The Ministry of Health’s online FluTracking initiative is boosting understanding of influenza.

Pharmacies nationwide are playing a key role in helping eligible people with diabetes change to new blood glucose meters. This is after Kiwi healthcare specialist Pharmaco (NZ) Limited was awarded the New Zealand sole supply agreement for blood glucose meters and strips by PHARMAC, late last year

The Pharmacy Guild of New Zealand (the Guild) is gearing up to hold our annual Pharmacy Business Network (PBN) in just over a month’s time, on Saturday 28 July 2018, at the Pullman Hotel in Auckland. 

Bayer has announced that from 1 June, EYLEA® (aflibercept) will be accessible as the second-line treatment option for Wet Age Related Macular Degeneration (wet-AMD) and Diabetic Macular Oedema (DMO) and will be made available in both hospitals and the community. PHARMAC funding was granted earlier this month and is expected to benefit around 900 people in its first year.¹

The Labour-led Government’s first Budget shows promise, the PSA says - but there are still many in the public and community service who will wonder when their turn is coming

Thousands of New Zealanders will benefit from advances in treatment as a result of two PHARMAC funding decisions

The Pharmacy Council of New Zealand has regretfully received the resignation of Deputy Chair, Leanne Te Karu. Chair, Mark Bedford, has sincerely thanked Leanne for her immense contribution over a seven-year period and has commended her for being a role model for the profession.